MarketPulse
Q

$QNTM

6 articles found
0 positive
4 negative
2 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Quantum BioPharma Closes $3.75M Private Placement, Settles $1.12M in Debt

Quantum BioPharma closes $3.75M debenture offering and settles $1.12M debt through equity issuance, strengthening balance sheet for business development.
QNTMClass B sharesworking capital
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Quantum BioPharma Adjusts Debenture Terms Amid Share Price Decline

Quantum BioPharma revises debenture offering terms following share price decline, lowering conversion price to $3.00 and increasing warrant allocation.
QNTMwarrantsbiopharmaceutical
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Quantum BioPharma Launches $4M Convertible Offering to Fund Operations

Quantum BioPharma raises capital through convertible debentures and debt-to-equity conversion to strengthen balance sheet and fund business development.
QNTMprivate placementcapital raising
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Class Action Lawsuit Targets Banks Over Alleged Quantum Biopharma Stock Manipulation

CIBC and RBC face class action lawsuit for allegedly using spoofed orders to manipulate Quantum Biopharma stock price downward, harming investors from 2021-2025.
RYCMQNTMsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Portnoy Law Firm

Law Firm Files Securities Class Action Against Quantum Biopharma Over Alleged Market Manipulation

Law firm sues Quantum Biopharma for alleged market manipulation through spoofed sell orders, claiming defendants artificially suppressed stock price from 2021-2025.
QNTMsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Pomerantz Files Securities Class Action Against Quantum Biopharma

Pomerantz Law Firm files class action against Quantum Biopharma, alleging Canadian banks used spoofed orders to artificially depress stock price and buy shares at reduced rates.
RYQNTMsecurities fraudclass action lawsuit